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Only a minority of cancer cells have the potential to initiate metastatic growth, but the factors that limit
metastatic colonization remain mostly unknown. Malanchi et al. (2012) recently demonstrated that stromal
periostin is crucial formetastatic colonization by regulating the interactions between breast cancer stem cells
and their metastatic niche.Tumor metastasis is the most common
cause of cancer-associated mortality. To
give rise to the outgrowth of metastatic
tumors in a new organ microenvironment,
cancer cells have to overcome various
types of stresses and several rate-limiting
steps (Bao et al., 2004). Most dissemi-
nated cancer cells are destroyed during
metastasis formation and only a small
subset of cancer cells are able to sur-
vive and colonize in a new environment.
Specialized tumor microenvironments
called metastatic niches are thought to
be responsible for nurturing disseminated
cancer cells from micrometastases to full
macrometastases. Recent studies have
shown that there may be a direct link
between cancer stem cells (CSCs) and
their metastatic niches. Identifying the
limiting factors that regulate the pro-
perties of CSCs and their colonization
of metastatic niches is therefore impor-
tant for developing strategies to treat
patients with metastatic tumors. In a
recent issue of Nature, Huelsken and
colleagues (Malanchi et al., 2012) provide
new insight into how signals from the
metastatic niche affect CSC self-renewal
and metastatic colonization.
CSCs are a subpopulation of tumor
cells that can drive tumorigenesis via their
abilities to self-renew and differentiate,
whereas their counterpart non-CSCs are
not tumorigenic and are thought to not
contribute substantially to tumor metas-
tasis. Recently, distinct types of CSCs
have been shown to determine tumor
growth and metastatic activity in human
pancreatic cancer (Hermann et al., 2007)
and colorectal/colon cancer (Dieter et al.,
2011; Pang et al., 2010). Using theMMTV-PyMT mouse breast cancer model, which
hasmany characteristics similar to human
luminal breast cancer and spontaneously
metastasizes to the lungs, Malanchi et al.
(2012) found that only the CD90+CD24+
CSC population from primary tumors or
pulmonary metastases was able to pro-
duce lung metastases and initiate sec-
ondary metastases. This result, together
with those from previous studies, sup-
ports the idea that only the CSC subpopu-
lation is able to cause tumor metastasis
and that selective expansion of CSCs is
responsible for initiating metastasis.
Because the metastasis frequency is
much lower than the number of injected
CSCs, Malanchi et al. reasoned that spe-
cialized elements from the foreign micro-
environment might govern metastatic
colonization by affecting the maintenance
and expansion of CSCs in metastatic
sites. To explore the limiting factors
that determine metastatic success, the
authors analyzed potential niches in
mammary gland, bone, skin, and intestine
and identified periostin (Postn) as a
stromal factor of normal stem cell niches.
They demonstrated that POSTN is se-
creted by stromal aSMA+VIM+ fibroblasts
in the lungs of metastasis-positive ani-
mals, but not by tumor cells. Furthermore,
the authors found that while POSTN-
knockout MMTV-PyMT mice show no dif-
ferences in primary breast tumor volume
and morphology compared with wild-
type mice, they have a significantly
decreased pulmonary metastasis poten-
tial, and the metastatic efficiency of
POSTN-deficient tumor cells can be re-
scued in wild-type recipients. These
data suggest that stromal POSTN actsCell Stem Cell 10as a key regulatory factor for lung
metastasis of breast tumors. Interestingly,
POSTN expression is induced in the
lung stroma by infiltrating cancer cells.
POSTN expression was increased in iso-
lated primary lung fibroblasts treated
with TGF-b3 or TGF-b2 or cocultured
with tumor cells. Using a dominant-nega-
tive TGFbR2DTM, the authors found that
blocking the action of TGF-b3 in tumor
cells abrogates stromal POSTN expres-
sion and metastasis formation in lungs.
Taken together, these results indicate
that infiltrating tumor cells can educate
stromal cells by secreting factors such as
TGF-b3, which induces host stromal ex-
pression of POSTN to create a metastatic
niche to support metastasis formation.
Investigating the underlying mecha-
nisms of POSTN-induced metastasis,
Malanchi et al. (2012) observed that
POSTN-deficient tumor cells fail to form
tumorspheres, but this phenotype can
be rescued by adding POSTN protein to
primary cultures. Furthermore, CSCs fail
to initiate colony formation when cocul-
tured with stromal cells isolated from
Postn/ lungs, but do form colonies
with wild-type cells. CD90+ CSCs have
a tendency to preferentially localize adja-
cent to stromal niches in lungmetastases,
whereas the frequency of CD90+CD24+
CSCs in the rare pulmonary metastases
in POSTN-deficient mice is reduced.
Thus, stromal POSTN plays a key role in
regulating CSC maintenance and expan-
sion during metastatic colonization. To
investigate how POSTN promotes stem
cell maintenance and metastasis forma-
tion, Malanchi et al. (2012) analyzed the
interactome of POSTN and found that, February 3, 2012 ª2012 Elsevier Inc. 111
Figure 1. Periostin Mediates the Crosstalk between Cancer Stem Cells and Their Niche
Periostin (POSTN) plays an essential role in the crosstalk between cancer stem cells (CSCs) and their niche
to permit metastatic colonization. (A) Tumor metastasis is initially triggered by cancer stem-like cells.
(B and C) The premetastatic niche created by bone-marrow-derived cells is critical for tumor metastasis
because it enhances the adhesion of infiltrating tumor cells. (D) Tumor-cell-secreted TGF-b3 educates the
lung stroma to create a CSC-supportive niche by inducing the expression of stromal POSTN. POSTN
recruits Wnt ligands, thereby augmenting Wnt signaling in CSCs, which promotes CSC self-renewal
and metastatic formation. (E) POSTN promotes tumor metastatic growth by promoting both cell survival
and angiogenesis. However, whether POSTN is involved in the formation of the premetastatic and
perivascular niches, and thereby in the regulation of CSC maintenance and tumor metastasis, has not
been characterized (C and F).
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teracting with Wnt ligands, Wnt1 and
Wnt3A. Interestingly, POSTN-deficient
mice successfully form pulmonary metas-
tasis under orthotopical MMTV-Wnt1
tumor cell transplantation. These results
suggest that stromal POSTN bridges the
gap between the metastatic niche and
CSCs to create a CSC-supportive niche
and promotes metastatic colonization
by augmenting Wnt signaling pathway
(Figure 1).
Interestingly, Bao et al. (2004) showed
previously that overexpression of POSTN
in human colon cancer cells can enhance
the number and size of metastases in the
liver, indicating that POSTNplays a critical112 Cell Stem Cell 10, February 3, 2012 ª201role in establishing metastases in the liver
microenvironment. These findings are
consistent with the conclusion of Malan-
chi et al. (2012) that POSTN is a critical
limiting factor during metastatic coloni-
zation. POSTN can also be secreted
by bone-marrow-derived mesenchymal
stromal cells and their derived cells
(Coutu et al., 2008), and Kaplan et al.
(2005) highlighted that the premetastatic
niche created by bone-marrow-derived
cells in secondary sites before the arrival
of tumor cells can be a critical microenvi-
ronment for facilitating tumor metastasis,
suggesting another potential site for
POSTN involvement. Further investigation
will no doubt increase our understanding2 Elsevier Inc.of the role of POSTN in tumor metastasis
in all of these locations.
The study from Malanchi et al. (2012)
reinforces the notion that there may
be functional similarities between matri-
cellular proteins in regulating CSC stem-
ness and metastatic niches. Osteopontin
(OPN), tenascin C, and other matricellular
proteins also promote tumor metastasis
and modulate the maintenance and ex-
pansion of normal or cancer stem cells
and metastatic niches (McAllister et al.,
2008; Oskarsson et al., 2011; Ouyang
et al., 2010). Whether and how these
matricellular proteins regulate stemness
of CSCs as metastatic niche components
deserves a systemic evaluation.
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